Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms. — Stella

View on ClinicalTrials.gov

Recruiting

Back to Apathy trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

United States

LSU Health Shreveport, Shreveport, Louisiana

Key details

Phase

Large-scale testing

Sponsor

Louisiana State University Health Sciences Center Shreveport

Enrollment target

~80 participants

Started

June 2024

Primary completion

December 2026

Age range

18 Years – 65 Years

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.